ConcertAI Appoints Timothy Albury as Chief Financial Officer
CAMBRIDGE, Mass., June 10, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World...
Month: June 2024
Wellness Essentials At Your Fingertips: Skip Welcomes Rexall to Its Retail Lineup Just in Time for Summer!
Rexall and Skip are helping Canadians make the most of their summer moments by delivering same-day pharmacy offerings TORONTO, June...
Bulletin from the 2024 Annual General Meeting of Spago Nanomedical AB
LUND, SE / ACCESSWIRE / June 10, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) The Annual General Meeting (AGM) of Spago Nanomedical...
AGFA HealthCare: Leading the Way in Imaging Innovation at SIIM 2024
MORTSEL, BELGIUM / ACCESSWIRE / June 10, 2024 / We're thrilled to announce our participation in the upcoming Society for...
America’s Health Insurance Plans Annual Institute & Expo Showcases Top-Performing Payer Technologies, Announces 2024 Black Book Survey Results
LAS VEGAS, NV / ACCESSWIRE / June 10, 2024 / Black Book Research recognizes the leading companies across diverse IT...
iZafe Group presents at Stora Aktiedagarna
STOCKHOLM, SWEDEN / ACCESSWIRE / June 10, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group (publ.) hereby announces that CEO Anders...
KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah
Community care events to be held throughout summer at Curaleaf's Lehi, Provo, and Payson, Utah Medical Cannabis Pharmacies SALT LAKE...
Bye, Bye Brain Fog: Zurge’s Proprietary Coffee Blend Sharpens Memory and Increases Mental Clarity
Formulated with breakthrough ingredient CognatiQ, this all-natural coffee is like no other Irving, TX – Zurvita is changing the morning...
Harris Williams Announces That Sam Hendler Rejoins Firm as Managing Director Focused on Healthcare IT
RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams, a global investment bank specializing in M&A and private capital advisory services, today announced that Sam...
Goshen Hospital Achieves Magnet with Distinction(TM) Recognition
Goshen, Indiana--(Newsfile Corp. - June 10, 2024) - Magnet recognition is one of the highest honors a healthcare organization can...
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - June 10, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a...
Galimedix Therapeutics Establishes Scientific Advisory Board of Renowned Retina Experts as Company Prepares to Enter Phase 2 Clinical Study with GAL-101
Board consists of key opinion leaders from both clinical practice and academia with strong track records in the development of...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
ANN ARBOR, MI / ACCESSWIRE / June 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
mRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines...
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
Live video webcast on Monday, June 17th at 1:00 PM ETOCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML
- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - - Overall Response Rate (ORR) of...
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical models Treatment with...
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
June 10, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial...
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...